Human Gene MIR205HG (uc009xcn.3) Description and Page Index
  Description: Homo sapiens MIR205 host gene (non-protein coding) (MIR205HG), mRNA.
Transcript (Including UTRs)
   Position: hg19 chr1:209,602,168-209,605,892 Size: 3,725 Total Exon Count: 4 Strand: +
Coding Region
   Position: hg19 chr1:209,602,643-209,605,694 Size: 3,052 Coding Exon Count: 3 

Page IndexSequence and LinksGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA Structure
Other SpeciesmRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:209,602,168-209,605,892)mRNA (may differ from genome)Protein (102 aa)
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSCGAP
EnsemblExonPrimerGeneCardsGeneNetworkH-INVHGNC
HPRDLynxMGIPubMedStanford SOURCE

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 84.68 RPKM in Esophagus - Mucosa
Total median expression: 379.22 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -102.11383-0.267 Picture PostScript Text
3' UTR -45.00198-0.227 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  AK091113 - Homo sapiens cDNA FLJ33794 fis, clone CTONG1000009.
AX746785 - Sequence 310 from Patent EP1308459.
JD357636 - Sequence 338660 from Patent EP1572962.
JD411717 - Sequence 392741 from Patent EP1572962.
JD102159 - Sequence 83183 from Patent EP1572962.
JD327768 - Sequence 308792 from Patent EP1572962.
JD432823 - Sequence 413847 from Patent EP1572962.
JD296041 - Sequence 277065 from Patent EP1572962.
JD523146 - Sequence 504170 from Patent EP1572962.
JD454077 - Sequence 435101 from Patent EP1572962.
JD295480 - Sequence 276504 from Patent EP1572962.
JD330328 - Sequence 311352 from Patent EP1572962.
JD256598 - Sequence 237622 from Patent EP1572962.
JD312508 - Sequence 293532 from Patent EP1572962.
JD312509 - Sequence 293533 from Patent EP1572962.
JD347711 - Sequence 328735 from Patent EP1572962.
JD351106 - Sequence 332130 from Patent EP1572962.
JD098563 - Sequence 79587 from Patent EP1572962.
JD495871 - Sequence 476895 from Patent EP1572962.
AK002208 - Homo sapiens cDNA FLJ11346 fis, clone PLACE1010900.
BC063704 - Homo sapiens cDNA clone IMAGE:4804382, partial cds.
CS266462 - Sequence 154 from Patent WO2005118806.
DL076624 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004274 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM175413 - A nucleics Acid regulating cell growth.
FU261283 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763785 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW418941 - METHOD FOR DISTINGUISHING BETWEEN LUNG SQUAMOUS CARCINOMA AND OTHER NON SMALL CELL LUNG CANCERS.
FW421616 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FZ435733 - JP 2011501949-A/50: DIAGNOSIS AND PROGNOSIS OF SPECIFIC CANCERS.
HV304684 - JP 2009531018-A/251: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305182 - JP 2009531019-A/251: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW101997 - JP 2013500034-A/124: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119391 - JP 2013046612-A/251: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367487 - JP 2012228254-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411880 - JP 2014000079-A/154: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505287 - JP 2014502606-A/189: MELANOMA TREATMENTS.
HW576249 - JP 2014509522-A/30: METHODS FOR LUNG CANCER CLASIFICATION.
HW589720 - JP 2013121348-A/251: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674226 - JP 2014217381-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ043255 - JP 2015510401-A/345: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067168 - JP 2014012020-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081881 - JP 2015514392-A/345: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408342 - JP 2015528002-A/939: CHIRAL CONTROL.
HZ413524 - JP 2014060993-A/251: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427592 - JP 2014217384-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428395 - JP 2014217385-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429198 - JP 2014217386-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430001 - JP 2014217387-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501735 - JP 2016025853-A/251: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769258 - JP 2014223080-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058652 - Sequence 154 from Patent EP2298893.
JA059455 - Sequence 154 from Patent EP2298894.
JA073778 - Sequence 154 from Patent EP2281887.
JA104915 - Sequence 154 from Patent EP2302051.
JA106255 - Sequence 154 from Patent EP2302052.
JA107058 - Sequence 154 from Patent EP2302053.
JA107861 - Sequence 154 from Patent EP2302054.
JA108664 - Sequence 154 from Patent EP2302055.
JA109467 - Sequence 154 from Patent EP2302056.
JA187238 - Sequence 7 from Patent WO2011018506.
JA191983 - Sequence 154 from Patent EP2290066.
JA192882 - Sequence 154 from Patent EP2290067.
JA193781 - Sequence 154 from Patent EP2290068.
JA194680 - Sequence 154 from Patent EP2290069.
JA195579 - Sequence 154 from Patent EP2290070.
JA196478 - Sequence 154 from Patent EP2290071.
JA197377 - Sequence 154 from Patent EP2290072.
JA198276 - Sequence 154 from Patent EP2290073.
JA199175 - Sequence 154 from Patent EP2290074.
JA200074 - Sequence 154 from Patent EP2290075.
JA200973 - Sequence 154 from Patent EP2290076.
JA218095 - Sequence 154 from Patent EP2281888.
JA226246 - Sequence 154 from Patent EP2292755.
JA229101 - Sequence 154 from Patent EP2292756.
JA254171 - Sequence 7 from Patent EP2283846.
JA257372 - Sequence 154 from Patent EP2284265.
JA278652 - Sequence 154 from Patent EP2281886.
JA284538 - Sequence 154 from Patent EP2281889.
JA292591 - Sequence 154 from Patent EP2287303.
JA317777 - Sequence 154 from Patent EP2314688.
JA374836 - Sequence 154 from Patent EP2322616.
JA526101 - Sequence 251 from Patent EP2369011.
JA526608 - Sequence 251 from Patent EP2369012.
JA527115 - Sequence 251 from Patent EP2369013.
JA536044 - Sequence 251 from Patent EP2371971.
JA788049 - Sequence 251 from Patent EP2479285.
JA788547 - Sequence 251 from Patent EP2479286.
JA810881 - Sequence 251 from Patent EP2468890.
JA811379 - Sequence 251 from Patent EP2468891.
JA811877 - Sequence 251 from Patent EP2468893.
JA812375 - Sequence 251 from Patent EP2468894.
JA812873 - Sequence 251 from Patent EP2468895.
JA813371 - Sequence 251 from Patent EP2468896.
JA813869 - Sequence 251 from Patent EP2468897.
JA814367 - Sequence 251 from Patent EP2468898.
JA814865 - Sequence 251 from Patent EP2468899.
JA817108 - Sequence 251 from Patent EP2468892.
JA825920 - Sequence 251 from Patent EP2471956.
JA826418 - Sequence 251 from Patent EP2471958.
JB024705 - Sequence 251 from Patent EP2505668.
JB025203 - Sequence 251 from Patent EP2505669.
JB037966 - Sequence 82 from Patent WO2012107841.
JB079590 - Sequence 251 from Patent EP2487252.
JB080088 - Sequence 251 from Patent EP2487253.
JB080586 - Sequence 251 from Patent EP2487254.
JB081084 - Sequence 251 from Patent EP2487255.
JB081582 - Sequence 251 from Patent EP2487256.
JB082080 - Sequence 251 from Patent EP2487257.
JB082578 - Sequence 251 from Patent EP2487258.
JB083076 - Sequence 251 from Patent EP2487259.
JB083574 - Sequence 251 from Patent EP2487260.
JB084072 - Sequence 251 from Patent EP2487261.
JB084570 - Sequence 251 from Patent EP2487262.
JB085068 - Sequence 251 from Patent EP2487263.
JB087746 - Sequence 251 from Patent EP2502630.
JB147950 - Sequence 251 from Patent EP2484782.
JB148448 - Sequence 251 from Patent EP2484783.
JB153173 - Sequence 251 from Patent EP2514433.
JB153671 - Sequence 251 from Patent EP2514434.
JB622260 - Sequence 251 from Patent EP2586454.
JB622758 - Sequence 251 from Patent EP2586455.
JC001821 - Sequence 251 from Patent EP2591794.
JC037575 - Sequence 103 from Patent EP2643479.
JC221679 - Sequence 154 from Patent EP2471923.
JC268245 - Sequence 154 from Patent EP2471924.
JC340553 - Sequence 154 from Patent EP2471922.
JC469799 - Sequence 154 from Patent EP2471921.
JC990588 - Sequence 154 from Patent EP2808390.
LF404352 - JP 2015509366-A/345: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF714691 - JP 2016165292-A/154: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856625 - JP 2015142597-A/154: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051676 - KR 1020150036642-A/942: CHIRAL CONTROL.
LP909368 - Sequence 29 from Patent EP3214174.
LQ101377 - Sequence 82 from Patent WO2015101653.
LQ276092 - Sequence 82 from Patent WO2016071729.
LX074088 - JP 2017060484-A/30: METHODS FOR LUNG CANCER CLASIFICATION.
LZ215745 - JP 2017518753-A/96: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA259185 - JP 2017502699-A/82: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA353883 - JP 2018075017-A/345: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
CS266649 - Sequence 341 from Patent WO2005118806.
DL076811 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004461 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421803 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367674 - JP 2012228254-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW412067 - JP 2014000079-A/341: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674413 - JP 2014217381-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067355 - JP 2014012020-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427779 - JP 2014217384-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428582 - JP 2014217385-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429385 - JP 2014217386-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430188 - JP 2014217387-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769445 - JP 2014223080-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058839 - Sequence 341 from Patent EP2298893.
JA059642 - Sequence 341 from Patent EP2298894.
JA073965 - Sequence 341 from Patent EP2281887.
JA105102 - Sequence 341 from Patent EP2302051.
JA106442 - Sequence 341 from Patent EP2302052.
JA107245 - Sequence 341 from Patent EP2302053.
JA108048 - Sequence 341 from Patent EP2302054.
JA108851 - Sequence 341 from Patent EP2302055.
JA109654 - Sequence 341 from Patent EP2302056.
JA192170 - Sequence 341 from Patent EP2290066.
JA193069 - Sequence 341 from Patent EP2290067.
JA193968 - Sequence 341 from Patent EP2290068.
JA194867 - Sequence 341 from Patent EP2290069.
JA195766 - Sequence 341 from Patent EP2290070.
JA196665 - Sequence 341 from Patent EP2290071.
JA197564 - Sequence 341 from Patent EP2290072.
JA198463 - Sequence 341 from Patent EP2290073.
JA199362 - Sequence 341 from Patent EP2290074.
JA200261 - Sequence 341 from Patent EP2290075.
JA201160 - Sequence 341 from Patent EP2290076.
JA218282 - Sequence 341 from Patent EP2281888.
JA226433 - Sequence 341 from Patent EP2292755.
JA229288 - Sequence 341 from Patent EP2292756.
JA257559 - Sequence 341 from Patent EP2284265.
JA278839 - Sequence 341 from Patent EP2281886.
JA284725 - Sequence 341 from Patent EP2281889.
JA292778 - Sequence 341 from Patent EP2287303.
JA317964 - Sequence 341 from Patent EP2314688.
JA375023 - Sequence 341 from Patent EP2322616.
JC221866 - Sequence 341 from Patent EP2471923.
JC268432 - Sequence 341 from Patent EP2471924.
JC340740 - Sequence 341 from Patent EP2471922.
JC469986 - Sequence 341 from Patent EP2471921.
JC990775 - Sequence 341 from Patent EP2808390.
LF714878 - JP 2016165292-A/341: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856812 - JP 2015142597-A/341: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW644040 - JP 2014195438-A/6: CELL PROLIFERATION INHIBITOR AND PREVENTING OR TREATING AGENT OF CANCER.
FM956499 - Homo sapiens microRNA miR-205-3P.
HI965301 - Sequence 586 from Patent WO2010139812.
HW101945 - JP 2013500034-A/72: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505604 - JP 2014502606-A/506: MELANOMA TREATMENTS.
HZ074038 - JP 2013535982-A/129: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ479939 - JP 2015535430-A/445: TERMINALLY MODIFIED RNA.
HZ789870 - JP 2016504050-A/1615: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287390 - Sequence 72 from Patent WO2011015720.
JA401339 - Sequence 586 from Patent WO2011080318.
JA402317 - Sequence 586 from Patent WO2011080315.
JA403324 - Sequence 586 from Patent WO2011080316.
JA405955 - Sequence 586 from Patent EP2336353.
JA429481 - Sequence 586 from Patent WO2011095623.
JB037968 - Sequence 84 from Patent WO2012107841.
JB620214 - Sequence 194 from Patent WO2013063544.
JC037657 - Sequence 185 from Patent EP2643479.
JC512602 - Sequence 2855 from Patent WO2014113089.
JC531644 - Sequence 64 from Patent WO2014082644.
LF161928 - JP 2016513950-A/1994: Oligomers with improved off-target profile.
LP909354 - Sequence 15 from Patent EP3214174.
LQ070190 - Sequence 514 from Patent EP2964234.
LQ101379 - Sequence 84 from Patent WO2015101653.
LQ276094 - Sequence 84 from Patent WO2016071729.
MA259187 - JP 2017502699-A/84: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA267340 - JP 2018061445-A/74: Method for detecting urothelial cancer based on microRNA in urine using cell sorting.
MS834440 - Sequence 586 from Patent EP3112479.
JD288206 - Sequence 269230 from Patent EP1572962.
JD515905 - Sequence 496929 from Patent EP1572962.
AY320401 - Homo sapiens nasopharyngeal carcinoma-associated antigen NPC-A-5 mRNA, complete cds.
JD474641 - Sequence 455665 from Patent EP1572962.
JD056187 - Sequence 37211 from Patent EP1572962.
JD189292 - Sequence 170316 from Patent EP1572962.
JD318714 - Sequence 299738 from Patent EP1572962.
JD068236 - Sequence 49260 from Patent EP1572962.
JD174930 - Sequence 155954 from Patent EP1572962.
JD273887 - Sequence 254911 from Patent EP1572962.
JD048389 - Sequence 29413 from Patent EP1572962.
MA643691 - JP 2017113010-A/1615: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731575 - JP 2017140048-A/445: TERMINALLY MODIFIED RNA.
MA781719 - JP 2018153164-A/4: CELL PROLIFERATION INHIBITOR AND PREVENTING OR TREATING AGENT OF CANCER.
LQ945658 - Sequence 30 from Patent EP2691545.
MP045523 - Sequence 345 from Patent EP3401394.
MP084193 - Sequence 345 from Patent EP3401393.
MA800744 - JP 2018183181-A/1615: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.

-  Other Names for This Gene
  Alternate Gene Symbols: NM_001104548, NP_001098018
UCSC ID: uc009xcn.3
RefSeq Accession: NM_001104548

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_001104548.1
exon count: 4CDS single in 3' UTR: no RNA size: 899
ORF size: 309CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 661.00frame shift in genome: no % Coverage: 99.00
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.